🇺🇸 Valsartan + Amlodipine besilate in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain In Jaw — 2 reports (15.38%)
  2. Renal Failure — 2 reports (15.38%)
  3. Rotator Cuff Syndrome — 2 reports (15.38%)
  4. Abdominal Pain — 1 report (7.69%)
  5. Adrenal Insufficiency — 1 report (7.69%)
  6. Ageusia — 1 report (7.69%)
  7. Angina Pectoris — 1 report (7.69%)
  8. Anosmia — 1 report (7.69%)
  9. Appendicitis — 1 report (7.69%)
  10. Aptyalism — 1 report (7.69%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Valsartan + Amlodipine besilate approved in United States?

Valsartan + Amlodipine besilate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Valsartan + Amlodipine besilate in United States?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.